NIAID Emerging and Re-emerging Infectious Diseases NIAID Bioinformatics Resource Centers NIAID Structural Genomic Centers Center for Structural Genomics of Infectious Disease
Seattle Structural Genomics Center for Infectious Disease

MygeA.19975.a: MgpA Bifunctional oligoribonuclease and PAP phosphatase NrnA (MG190) (MG_190)

Target Characteristics

from organism: Mycoplasma genitalium ATCC 33530 / G-37 / NCTC 10195
most recent status: cloned
center reference id: MygeA.19975.a
is community request: True
associated disease:
NIH risk group: unclassified
is select agent: False
NIH priority
pathogens category:
C

Ordering Clones & Proteins

If there are materials available for this target, they will be listed below. Materials can be ordered from SSGCID using the button in the "order material" column. Clicking the button will add the material to a virtual cart. You may order multiple materials at a time at no cost to you, as this contract is funded by NIAID. When you are ready to place your order, click the "Place Order" link which will appear in the top right corner of the page after you place your first item in your cart.

Clones*

CENTER
REFERENCE ID
DOMAIN/REGION
DESCRIPTION
INFO AA
START
AA
STOP
ORDER
MATERIAL
MygeA.19975.a.B2.GE42348 DDH domain 18 160 GE42348
* SSGCID clones represent un-induced expression constructs which have been verified by sequencing from vector primers. Clones may contain a tag, such as N-term 6xHis. Get sequence information using the button in the "info" column.

Molecular models

Method Results
comparative modelling Robetta_81202

External Resources

Resource Reference ID
PATRIC ID: fig|243273.25.peg.218
UniProt: P22746

Enzyme & Pathway Information

Pathway Pathway ID EC Number
3.1.3.7

Sequences

These sequences are the native gene sequence; sequences of constructs derived from these sequences may differ due to codon optimization or other protocols. To find the specific sequence of any material you may have ordered, click on the "more" button next to the name of that material.
AA Sequence
MKKGSITEAI NAIKQFDKIV IFHHVRPDGD CLGAQQGLFH LIKANFKNKE VKCVGNNNNL FSFINMTFTN QIDESFLKEA LAIVVDANYK NRIELRELLD KNLFKAVLRI DHHPNEDDLN TSFNFVEESY VACCEQIVEM ATVAKWTIPP VAATLLYIGI YTDSNRFLYS NTSYRTLYLA AILYKAKADI RIVHDHLNHT SLADLKFKKY VYNHFKTQGQ VIYFICTKKI QKRLRMTADQ CARVNLLSNI ADYKIWLFFI EQANNEIRID LRSNGINVRD IAIKYGGGGH NNASGAIITN KKQISDVVSD CVKKIVYN

NT Sequence
ATGAAAAAAG GATCAATAAC TGAAGCAATT AATGCCATTA AACAATTTGA TAAGATTGTT ATCTTTCACC ATGTGCGCCC TGATGGGGAT TGTTTAGGAG CACAACAAGG CTTGTTTCAC CTCATTAAAG CTAACTTTAA AAATAAGGAG GTGAAGTGTG TTGGTAATAA CAACAACCTG TTTAGCTTTA TCAACATGAC ATTTACCAAC CAAATTGATG AGAGCTTTTT AAAAGAAGCA CTTGCCATTG TGGTCGATGC TAATTACAAA AACAGGATTG AATTGAGAGA ACTGTTAGAT AAAAACCTGT TTAAAGCAGT GTTAAGGATT GATCACCATC CCAATGAAGA TGATCTAAAC ACTAGCTTTA ACTTTGTTGA AGAAAGCTAT GTAGCTTGTT GTGAGCAGAT AGTGGAGATG GCCACAGTGG CGAAGTGGAC CATACCACCA GTGGCTGCTA CTTTACTATA TATAGGTATC TATACGGATA GTAATAGATT TCTATATAGT AATACATCAT ATAGAACACT ATACTTAGCA GCAATACTAT ATAAAGCTAA AGCTGATATA AGGATAGTAC ATGATCATTT AAACCATACT AGTTTAGCAG ATCTTAAGTT TAAAAAGTAT GTTTATAACC ACTTTAAAAC CCAAGGACAA GTGATCTATT TTATCTGTAC TAAAAAGATC CAAAAGAGAC TAAGAATGAC TGCAGATCAA TGTGCTAGAG TTAACTTGTT AAGTAACATA GCAGATTACA AGATCTGACT TTTCTTTATT GAACAAGCTA ATAATGAGAT CAGGATAGAA CTGAGGAGTA ATGGGATTAA TGTCAGAGAT ATAGCCATTA AGTATGGTGG GGGAGGACAT AATAATGCAA GTGGAGCGAT CATTACTAAC AAAAAACAAA TTAGTGATGT TGTTAGTGAT TGTGTGAAAA AAATTGTTTA TAAT

© 2020 Seattle Children's Research Institute. All rights reserved.